Loading...
Market
Will Neuralink receive FDA approval to expand N1 Implant trial by Jun 30, 2025?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
FDA announcements or Neuralink press releases
Story
Neuralink Launches Trial of N1 Brain Implant to Control Robotic Arm in Paralyzed Patients
Nov 25, 2024, 07:45 PM
Neuralink announced the launch of a new feasibility study, named 'CONVOY', to extend brain-computer interface (BCI) control using the N1 Implant to an investigational assistive robotic arm. The study aims to evaluate the safety and effectiveness of the implant in patients with quadriplegia, allowing them to control external devices with their thoughts. This development represents an important step towards restoring physical freedom to individuals with paralysis.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
